(SR) Gliclazide Pioglitazone and (SR) Metformin HCL '''

Gliclazide (SR) Pioglitazone and Metformin HCL (SR)
TRIGLICLAGLAZE 30  
Gliclazide is an oral antidiabetic medication belonging to the sulfonylurea class. It works by stimulating the pancreas to release more insulin, which helps lower blood sugar levels. Gliclazide is particularly effective in improving post-meal glucose control.
Pioglitazone is a thiazolidinedione (TZD) medication that primarily improves insulin sensitivity in muscle and adipose tissue. It enhances the body's ability to use insulin more effectively, leading to better blood sugar control. Pioglitazone also reduces the production of glucose in the liver.
Metformin Hydrochloride is a biguanide medication that works by reducing the production of glucose in the liver and improving insulin sensitivity in muscle tissue. It is often considered the first-line treatment for type 2 diabetes and is known for its beneficial effects on weight management.
TRIGLICLAGLAZE is available in strengths of 30mg and 60mg .
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/trigliclaglaze-30-134278